Detalhe da pesquisa
1.
Genome-wide aggregated trans-effects on risk of type 1 diabetes: A test of the "omnigenic" sparse effector hypothesis of complex trait genetics.
Am J Hum Genet
; 110(6): 913-926, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37164005
2.
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
N Engl J Med
; 389(24): 2221-2232, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952131
3.
Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.
Diabetologia
; 2024 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38795153
4.
Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study.
Diabetologia
; 65(1): 159-172, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34618177
5.
Development and validation of a cardiovascular risk prediction model in type 1 diabetes.
Diabetologia
; 64(9): 2001-2011, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34106282
6.
The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes.
Diabetologia
; 64(6): 1309-1319, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33608768
7.
Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.
Diabetologia
; 64(6): 1320-1331, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686483
8.
Quantitative levels of serum N-glycans in type 1 diabetes and their association with kidney disease.
Glycobiology
; 31(5): 613-623, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33245334
9.
Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study.
BMC Med
; 19(1): 149, 2021 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34158021
10.
Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study.
BMC Med
; 19(1): 51, 2021 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33612113
11.
Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND.
Cardiovasc Diabetol
; 20(1): 194, 2021 09 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34563178
12.
Metformin and carotid intima-media thickness in never-smokers with type 1 diabetes: The REMOVAL trial.
Diabetes Obes Metab
; 23(6): 1371-1378, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33591613
13.
Association of cerebral venous thrombosis with recent COVID-19 vaccination: case-crossover study using ascertainment through neuroimaging in Scotland.
BMC Infect Dis
; 21(1): 1275, 2021 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34930153
14.
Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus.
Diabetologia
; 63(3): 636-647, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31807796
15.
Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004-2017.
Diabetologia
; 63(8): 1626-1636, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32451572
16.
Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes.
Diabetologia
; 63(4): 788-798, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31915892
17.
Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.
PLoS Med
; 17(10): e1003374, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33079969
18.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Lancet
; 394(10193): 121-130, 2019 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189511
19.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Lancet
; 394(10193): 131-138, 2019 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189509
20.
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design.
Am Heart J
; 229: 61-69, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32916609